With the surging popularity of GLP-1 weight-loss drugs, millions of Americans are poised to collectively shed hundreds of millions of pounds over the next decade — and reshuffle trillions of dollars in the process. In other words, the stock market is getting Ozempic'ed. That accelerating trend was on …
